Skip to content
10-Q

Quarterly Report

GeneThera, Inc.

0001575872-22-001091

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 14, 2022 35.33M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$2.57K
Operating Cash Flow Q3 2022 · Sep 30, 2021 $1.33K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$8.54M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$8.42M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$8.17M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$8.05M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$8.01M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$7.68M
Total Liabilities Q3 2022 · Sep 30, 2022 $8.54M
Total Liabilities Q3 2022 · Dec 31, 2021 $8.18M
Current Assets Q3 2022 · Sep 30, 2022 $0
Current Assets Q3 2022 · Dec 31, 2021 $1.02K
Total Assets Q3 2022 · Sep 30, 2022 $1.32K
Total Assets Q3 2022 · Dec 31, 2021 $6.3K
Net Income Q3 2022 · Sep 30, 2022 −$125.57K
Net Income Q3 2022 · Sep 30, 2022 −$406.26K
Net Income Q3 2022 · Sep 30, 2021 −$243.87K
Net Income Q3 2022 · Sep 30, 2021 −$736.48K
Operating Income Q3 2022 · Sep 30, 2022 −$125.02K
Operating Income Q3 2022 · Sep 30, 2022 −$404.59K
Operating Income Q3 2022 · Sep 30, 2021 −$242.22K
Operating Income Q3 2022 · Sep 30, 2021 −$731.54K